Lu, X., Gu, W., Shi, G., & Ye, D. (2021). Pazopanib together with 6–8 cycles of sintilimab followed by single use of pazopanib in the second-line treatment of advanced renal cell carcinoma. Transl Androl Urol.
Dyfyniad Arddull ChicagoLu, Xiaolin, Weijie Gu, Guohai Shi, and Dingwei Ye. "Pazopanib Together With 6–8 Cycles of Sintilimab Followed By Single Use of Pazopanib in the Second-line Treatment of Advanced Renal Cell Carcinoma." Transl Androl Urol 2021.
Dyfyniad MLALu, Xiaolin, Weijie Gu, Guohai Shi, and Dingwei Ye. "Pazopanib Together With 6–8 Cycles of Sintilimab Followed By Single Use of Pazopanib in the Second-line Treatment of Advanced Renal Cell Carcinoma." Transl Androl Urol 2021.
Rhybudd: Mae'n bosib nad yw'r dyfyniadau hyn bob amser yn 100% cywir.